Toshiaki Sato
PharmaEssentia JP · PharmaEssentia Japan K.K.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Toshiaki Sato as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:54 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06468033 · P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 RiskPharmaEssentia · active not recruiting · Primary Myelofibrosis, Myeloproliferative Neoplasm · study director
- Ph3NCT04285086 · Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or IntolerancePharmaEssentia · active not recruiting · Essential Thrombocythemia · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:54 UTC. The ranking covers the 200 most relevant of 513 PubMed records, and a shared surname and initials can bring in a namesake. All 513 on PubMed
- 382 citationsRCR 15.5
- Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease.Neurobiol Aging · 2011333 citationsRCR 9.8
- A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease.Mol Ther · 2010259 citationsRCR 6.6
- 250 citationsRCR 23.0
- Frontal lobe function in bipolar disorder: a multichannel near-infrared spectroscopy study.Neuroimage · 2006206 citationsRCR 6.3
- Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men.Kidney Int · 2006203 citationsRCR 5.7
- Transcranial focused ultrasound modulates intrinsic and evoked EEG dynamics.Brain Stimul · 2014159 citationsRCR 6.0
- Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial.Nat Med · 2022150 citationsRCR 9.7
- 130 citationsRCR 10.8
- A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer.Cancer Chemother Pharmacol · 2018127 citationsRCR 4.7